Keyhanfar F

No ORCID on file · 4 papers in corpus
other 2022
BioMed research international ·doi:10.1155/2022/1111777

Studies suggest that ovarian hyperstimulation syndrome (OHSS) can be treated by reducing the level of vascular endothelial growth factor (VEGF). However, due to the side effects of commercially available VEGF-reducing drugs, they can be rul…

2021
Journal of Reproductive Immunology ·doi:10.1016/j.jri.2021.103384

Over the past two decades, nanotechnology has been involved in an array of applications in various fields, including diagnostic kits, disease treatment, drug manufacturing, drug delivery, and gene therapy. But concerns about the toxicity of…

other 2021
Canadian journal of physiology and pharmacology ·doi:10.1139/cjpp-2021-0094

Nanoparticles (NPs) have many toxic effects on fertility and can prevent successful implantation by affecting the maternal uterine tissue. Herein, by deploying 30 female NMRI mice, the effect of silver NPs on the endometrium and implantatio…

other 2020
International journal of reproductive biomedicine ·doi:10.18502/ijrm.v13i10.7765

BACKGROUND: Many researchers consider implantation and endometrial receptivity as pertinent issues in reproductive science. Although, several experiments have been performed and their results evaluated, yet there is no confirmed evidence ab…